Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy

Acta Anaesthesiologica Scandinavica

Volumn 51, Issue 9, 2007, Pages 1217-1224

  Guarracino, F ^a   Cariello, C ^a   Danella, A ^a   Doroni, L ^a   Lapolla, F ^a   Stefani, M ^a   Baldassarri, R ^a   Vullo, C ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Bypass; Coronary artery disease; Levosimendan; Myocardial function; Ventriculo arterial coupling

Indexed keywords

CISATRACURIUM; FLUNITRAZEPAM; LEVOSIMENDAN; PROPOFOL; REMIFENTANIL;

AGED; ARTERIAL PRESSURE; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR PERFORMANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DEMOGRAPHY; DRUG EFFECT; FEMALE; HEART EJECTION FRACTION; HEART INDEX; HEART LEFT VENTRICLE FAILURE; HUMAN; ISCHEMIA; LOADING DRUG DOSE; MALE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; SYSTEMIC VASCULAR RESISTANCE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; CARDIAC OUTPUT; FEMALE; HEART RATE; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIDAZINES; VASCULAR RESISTANCE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 34548591843     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2007.01428.x     Document Type: Article

References (37)

1. 2+) in guinea pig isolated ventricular myocytes. Eur J Pharmacol 1997 339 : 97 100.
2. Pagel PS, Harkin CP, Hettrick DA et al. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs. Anesthesiology 1994 81 : 974 87.
3. Givertz MM, Andreou C, Conrad CH. Direct myocardial effects of levosimendan, a novel calcium sensitizer, in human with left ventricular dysfunction. Circulation 1998 98 (Suppl. 17 I 579.
4. Hasenfuss G, Pieske B, Castell M. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 1998 98 : 2141 7.
5. Toller WG, Stranz C, Nieminen MS. Levosimendan, a new inotropic and vasodilator agent. Anaesthesiology 2006 104 : 556 69.
6. O'Connor CM, Gattis WA, Uretsky BF et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1999 138 : 78 86.
7. Packer M, Carver JR, Rodeheffer RJ et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991 325 : 1468 75.
8. Hasenfuss G, Holubarsch C, Heiss HW et al. Myocardial energetics in patients with dilated cardiomyopathy: influence of nitroprusside and enoximone. Circulation 1989 80 : 51 64.
9. Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Linden IB. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995 27 : 1859 66.
10. Haikala H, Nissinen E, Etemadzadeh E, Levijoki J, Linden IB. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 1995 25 : 794 801.
11. McGough MF, Pagel PS, Lowe D et al. Effects of levosimendan on left ventricular function: correlation with plasma concentrations in conscious dogs. J Cardiothorac Vasc Anesth 1997 11 : 49 53.
12. Sonntag S, Sundberg S, Lehtonen LA, Kleber FX. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. J Am Coll Cardiol 2004 43 : 2177 82.
13. Gruhn N, Nielsen Kudsk JE, Theilgaard S, Bang L, Olesen SP, Aldershvile J. Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium sensitizing properties. J Cardiovasc Pharmacol 1998 31 : 741 9.
14. Hohn J, Pataricza J, Petri A et al. Levosimendan interacts with potassium channel blockers in human saphenous veins. Basic Clin Pharmacol Toxicol 2004 94 : 271 3.
15. Follath F, Cleland JGF, Just H. Efficacy and safety of intravenous levosimendan in severe low-output heart failure. Circulation 1999 100 (Suppl. 1 I 646.
16. Follath F, Cleland JG, Just H et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002 360 : 196 202.
17. Delle Karth G, Buberl A, Geppert A et al. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anesthesiol Scand 2003 45 : 1251 6.
18. Moiseyev VS, Poder P, Andrejevs N et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controlled, doubleblind study (RUSSLAN). Eur Heart J 2002 23 : 1422 32.
19. Lilleberg J, Nieminen MS, Akkila J. Effect a new calcium sensiteizer, levosimendan, on haemodinamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998 19 : 660 8.
20. Nijhawan N, Nicolosi AC., Montgomery MW. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomised placebo-controlled trial. J Cardiovasc Pharmacol 1999 34 : 219 28.
21. Barisin S, Husedzinovic I, Sonicki Z, Bradic N, Barisin A, Tonkovic D. Levosimendan in off-pump coronary artery bypass: a four-times masked controlled study. J Cardiovasc Pharmacol 2004 44 : 703 8.
22. Asanoi H, Kameyama T, Ishizaka S et al. Ventriculo-arterial coupling during exercise in normal human subjects. Int J Cardiol 1992 36 : 177 86.
23. Kadoy Y, Kawahara H, Fujita N. The end-systolic pressure-Volume relationship and ventriculoarterial coupling in patients undergoing coronary artery by pass graft surgery. Acta Anaesthsiol Scand 1998 42 : 369 75.
24. Gorcsan J 3rd., Gasior TA, Mandarino WA, Deneault LG, Hattler BG, Pinsky MR. Assessment of the immediate effects of cardiopulmonary bypass on left ventricular performance by on-line pressure-area relations. Circulation 1994 89 : 180 90.
25. Yamaura K, Hoka S, Okamoto H, Takahashi S. Noninvasive assessment of left ventricular pressure-area relationship using transesophageal echocardiography and tonometry during cardiac and abdominal aortic surgery. J Anesth 2005 19 : 106 11.
26. Kelly R, Ting C, Yang T et al. Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992 86 : 513 21.
27. Burkhoff D, Sagawa K. Ventricular efficiency predicted by analytical model. Am J Physiol 1986 250 : 1021 7.
28. Pittarello D, Bonato R, Marcassa A et al. Ventricolo-arterial coupling and mechanical efficiency with remifentanil in patients with coronary artery disease. Acta Anaesthesiol Scand 2004 48 : 61 8.
29. Elzinga G, Westerhof N. Matching between ventricle and arterial load. Circ Res 1991 68 : 1495 500.
30. El Tobgi S, Fouad FM, Kramer JR et al. Left ventricular function in coronary artery disease. Evaluation of slope of end-systolic pressure-volume line (Emax) and ratio of peak systolic pressure to end-systolic volume (P/Ves). J Am Coll Cardiol 1984 3 : 781 8.
31. Sunagawa K, Maughan WL, Burkhoff D. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983 31 : 776 81.
32. O'Rourke MF. Vascular impedence in studies of arterial and cardiac function. Physiol Rev 1982 62 : 570 623.
33. Nozaky J, Kitahata H, Tanaka K, Kawahito S, Oshita S. Effect of acute normovolemic hemodiluition on ventriculoarterial coupling in dogs. Acta Anesthesiol Scand 2003 47 : 46 52.
34. Starling MR. Left ventricular-arterial coupling relations in the normal human heart. Am Heart J 1993 125 : 1659 66.
35. Sasayama S, Asanoi H. Coupling between the heart and arterial system in heart failure. Am J Med 1991 90 : 14 8 S.
36. Asanoi H, Sasayama S, Kameyama T. Ventriculoarterial coupling in normal and failing heart in humans. Circ Res 1989 65 : 483 93.
37. Cavana M, Pignataro C, Fraticelli A et al. The clinical experience with levosimendan in anesthesiology and in the intensive care unit. Ital Heart J 2003 4 (Suppl. 2 61S 64S.